more general categories |
information about this item |
|
1. Human Genes |
 |
 |
|
1. Human Genes |
|
|
follicle stimulating hormone, beta polypeptide [HGNC:FSHB] (68) |
|
|
luteinizing hormone beta polypeptide [HGNC:LHB] (47) |
|
|
estrogen receptor 1 [HGNC:ESR1] (506) |
|
|
estrogen receptor 2 (ER beta) [HGNC:ESR2] (261) |
|
|
UDP glucuronosyltransferase 1 family, polypeptide A1 [HGNC:UGT1A1] (167) |
|
|
UDP glucuronosyltransferase 1 family, polypeptide A3 [HGNC:UGT1A3] (94) |
|
|
UDP glucuronosyltransferase 1 family, polypeptide A9 [HGNC:UGT1A9] (108) |
|
|
UDP glucuronosyltransferase 2 family, polypeptide B15 [HGNC:UGT2B15] (85) |
|
 |
2. Interaction: Human Genes and Chemicals |
 |
 |
|
2. Interaction: Human Genes and Chemicals |
|
|
binding (2423) |
|
|
expression (2187) |
|
|
activity (2865) |
|
|
glucuronidation (189) |
|
|
metabolic processing (740) |
|
 |
C04. Neoplasms |
 |
 |
|
C04. Neoplasms |
|
|
|
|
|
|
|
|
Polycystic Ovary Syndrome [MESH:D011085] (2186) |
|
|
Leukemia [MESH:D007938] (4576) |
|
|
Hodgkin Disease [MESH:D006689] (1082) |
|
|
|
|
|
Leiomyoma [MESH:D007889] (744) |
|
|
|
|
|
|
|
|
|
|
|
Medulloblastoma [MESH:D008527] (1282) |
|
|
Medulloblastoma [MESH:D008527] (1282) |
|
|
|
|
|
Mesothelioma [MESH:D008654] (2567) |
|
|
Carcinoma, Small Cell [MESH:D018288] (1317) |
|
|
Carcinoma, Transitional Cell [MESH:D002295] (2662) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
Carcinoma, Renal Cell [MESH:D002292] (2975) |
|
|
Prostatic Intraepithelial Neoplasia [MESH:D019048] (1565) |
|
|
Mesothelioma [MESH:D008654] (2567) |
|
|
|
|
|
Medulloblastoma [MESH:D008527] (1282) |
|
|
Medulloblastoma [MESH:D008527] (1282) |
|
|
|
|
|
|
|
|
|
|
|
Medulloblastoma [MESH:D008527] (1282) |
|
|
Medulloblastoma [MESH:D008527] (1282) |
|
|
Breast Neoplasms [MESH:D001943] (6077) |
|
|
|
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
Colorectal Neoplasms [MESH:D015179] (5294) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
Mammary Neoplasms, Experimental [MESH:D008325] (3268) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Small Cell Lung Carcinoma [MESH:D055752] (1380) |
|
|
|
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
Urinary Bladder Neoplasms [MESH:D001749] (4079) |
|
|
Carcinoma, Renal Cell [MESH:D002292] (2975) |
|
|
Mammary Neoplasms, Experimental [MESH:D008325] (3268) |
|
|
Neoplasm Invasiveness [MESH:D009361] (3388) |
|
|
Neoplasm Metastasis [MESH:D009362] (4441) |
|
|
Neoplasm Recurrence, Local [MESH:D009364] (1949) |
|
|
Cell Transformation, Neoplastic [MESH:D002471] (3389) |
|
 |
C05. Musculoskeletal Diseases |
 |
 |
|
C05. Musculoskeletal Diseases |
|
|
|
|
|
Bone Diseases, Metabolic [MESH:D001851] (3492) |
|
|
|
|
|
Arthritis, Rheumatoid [MESH:D001172] (3603) |
|
|
Osteoarthritis [MESH:D010003] (1743) |
|
|
Arthritis, Rheumatoid [MESH:D001172] (3603) |
|
|
Osteoarthritis [MESH:D010003] (1743) |
|
 |
C06. Digestive System Diseases |
 |
 |
|
C06. Digestive System Diseases |
|
|
|
|
|
|
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
Colorectal Neoplasms [MESH:D015179] (5294) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
|
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
Colorectal Neoplasms [MESH:D015179] (5294) |
|
|
|
|
|
Colorectal Neoplasms [MESH:D015179] (5282) |
|
|
Colorectal Neoplasms [MESH:D015179] (5294) |
|
|
Colorectal Neoplasms [MESH:D015179] (4534) |
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
 |
C08. Respiratory Tract Diseases |
 |
 |
|
C08. Respiratory Tract Diseases |
|
|
|
|
|
|
|
|
|
|
|
Small Cell Lung Carcinoma [MESH:D055752] (1380) |
|
|
|
|
|
|
|
|
|
|
|
Small Cell Lung Carcinoma [MESH:D055752] (1380) |
|
 |
C10. Nervous System Diseases |
 |
 |
|
C10. Nervous System Diseases |
|
|
|
|
|
|
|
|
|
|
|
Kernicterus [MESH:D007647] (256) |
|
|
|
|
|
|
|
|
|
|
|
Lateral Medullary Syndrome [MESH:D014854] (188) |
|
|
|
|
|
|
|
|
Lateral Medullary Syndrome [MESH:D014854] (188) |
|
|
Alzheimer Disease [MESH:D000544] (4275) |
|
|
|
|
|
Migraine Disorders [MESH:D008881] (2318) |
|
|
|
|
|
|
|
|
Hyperprolactinemia [MESH:D006966] (603) |
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
|
|
|
|
|
|
Ceroid Lipofuscinosis, Neuronal, 10 [MESH:C566438] (159) |
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
Alzheimer Disease [MESH:D000544] (4275) |
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
Peripheral Nervous System Diseases [MESH:D010523] (6151) |
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
 |
C12. Male Urogenital Diseases |
 |
 |
|
C12. Male Urogenital Diseases |
|
|
|
|
|
|
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
|
|
|
|
|
|
Follicle-stimulating hormone deficiency, isolated [MESH:C537070] (185) |
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
|
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
Urinary Bladder Neoplasms [MESH:D001749] (4079) |
|
|
Carcinoma, Renal Cell [MESH:D002292] (2975) |
|
|
|
|
|
|
|
|
Carcinoma, Renal Cell [MESH:D002292] (2975) |
|
|
Glomerulonephritis [MESH:D005921] (3758) |
|
|
Acute Kidney Injury [MESH:D058186] (4142) |
|
|
Urinary Bladder Neoplasms [MESH:D001749] (4079) |
|
 |
C13. Female Urogenital Diseases and Pregnancy Complications |
 |
 |
|
C13. Female Urogenital Diseases and Pregnancy Complications |
|
|
Not Fully Specified [NFS] (1116) |
|
|
|
|
|
Endometriosis [MESH:D004715] (2461) |
|
|
|
|
|
|
|
|
Polycystic Ovary Syndrome [MESH:D011085] (2186) |
|
|
Infertility, Female [MESH:D007247] (2184) |
|
|
|
|
|
Urinary Bladder Neoplasms [MESH:D001749] (4079) |
|
|
Carcinoma, Renal Cell [MESH:D002292] (2975) |
|
|
|
|
|
|
|
|
Carcinoma, Renal Cell [MESH:D002292] (2975) |
|
|
Glomerulonephritis [MESH:D005921] (3758) |
|
|
Acute Kidney Injury [MESH:D058186] (4142) |
|
|
Urinary Bladder Neoplasms [MESH:D001749] (4079) |
|
 |
C14. Cardiovascular Diseases |
 |
 |
|
C14. Cardiovascular Diseases |
|
|
|
|
|
|
|
|
Bradycardia [MESH:D001919] (1899) |
|
|
Tachycardia [MESH:D013610] (3339) |
|
|
Hypertrophy, Left Ventricular [MESH:D017379] (1430) |
|
|
Acute Coronary Syndrome [MESH:D054058] (2286) |
|
|
Myocardial Infarction [MESH:D009203] (4122) |
|
|
Acute Coronary Syndrome [MESH:D054058] (2286) |
|
|
Coronary Artery Disease [MESH:D003324] (2685) |
|
|
Hypertension [MESH:D006973] (5655) |
|
|
|
|
|
Atherosclerosis [MESH:D050197] (4188) |
|
|
Coronary Artery Disease [MESH:D003324] (2685) |
|
|
|
|
|
|
|
|
|
|
|
Lateral Medullary Syndrome [MESH:D014854] (188) |
|
|
|
|
|
|
|
|
Lateral Medullary Syndrome [MESH:D014854] (188) |
|
|
Acute Coronary Syndrome [MESH:D054058] (2286) |
|
|
Myocardial Infarction [MESH:D009203] (4151) |
|
|
Acute Coronary Syndrome [MESH:D054058] (2286) |
|
|
Coronary Artery Disease [MESH:D003324] (2685) |
|
 |
C15. Hemic and Lymphatic Diseases |
 |
 |
|
C15. Hemic and Lymphatic Diseases |
|
|
|
|
|
|
|
|
Kernicterus [MESH:D007647] (256) |
|
|
|
|
|
|
|
|
Neutropenia [MESH:D009503] (1629) |
|
|
|
|
|
|
|
|
Hodgkin Disease [MESH:D006689] (1082) |
|
 |
C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
 |
 |
|
C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
|
|
|
|
|
|
|
|
|
|
|
Ceroid Lipofuscinosis, Neuronal, 10 [MESH:C566438] (159) |
|
|
|
|
|
Hyperbilirubinemia, Transient Familial Neonatal [MESH:C562692] (254) |
|
|
Gilbert Disease [MESH:D005878] (259) |
|
|
Crigler Najjar syndrome, type 2 [MESH:C536213] (254) |
|
|
|
|
|
|
|
|
Ceroid Lipofuscinosis, Neuronal, 10 [MESH:C566438] (159) |
|
|
|
|
|
Kernicterus [MESH:D007647] (256) |
|
|
Hyperbilirubinemia, Transient Familial Neonatal [MESH:C562692] (254) |
|
 |
C17. Skin and Connective Tissue Diseases |
 |
 |
|
C17. Skin and Connective Tissue Diseases |
|
|
|
|
|
Arthritis, Rheumatoid [MESH:D001172] (3603) |
|
|
|
|
|
Breast Neoplasms [MESH:D001943] (6077) |
|
 |
C18. Nutritional and Metabolic Diseases |
 |
 |
|
C18. Nutritional and Metabolic Diseases |
|
|
|
|
|
Kernicterus [MESH:D007647] (256) |
|
|
|
|
|
|
|
|
Ceroid Lipofuscinosis, Neuronal, 10 [MESH:C566438] (159) |
|
|
|
|
|
Hyperbilirubinemia, Transient Familial Neonatal [MESH:C562692] (254) |
|
|
Gilbert Disease [MESH:D005878] (259) |
|
|
Crigler Najjar syndrome, type 2 [MESH:C536213] (254) |
|
|
|
|
|
|
|
|
Ceroid Lipofuscinosis, Neuronal, 10 [MESH:C566438] (159) |
|
|
|
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
|
|
|
Obesity [MESH:D009765] (4462) |
|
 |
C19. Endocrine System Diseases |
 |
 |
|
C19. Endocrine System Diseases |
|
|
|
|
|
Hypogonadism [MESH:D007006] (1123) |
|
|
Puberty, Delayed [MESH:D011628] (449) |
|
|
|
|
|
Polycystic Ovary Syndrome [MESH:D011085] (2186) |
|
|
|
|
|
Hyperprolactinemia [MESH:D006966] (603) |
|
 |
C20. Immune System Diseases |
 |
 |
|
C20. Immune System Diseases |
|
|
|
|
|
Arthritis, Rheumatoid [MESH:D001172] (3601) |
|
|
|
|
|
Kernicterus [MESH:D007647] (256) |
|
|
|
|
|
|
|
|
Hodgkin Disease [MESH:D006689] (1082) |
|
 |
C22. Animal Diseases |
 |
 |
|
C22. Animal Diseases |
|
|
Disease Models, Animal [MESH:D004195] (2058) |
|
|
Mammary Neoplasms, Animal [MESH:D015674] (2735) |
|
 |
C23. Pathological Conditions, Signs and Symptoms |
 |
 |
|
C23. Pathological Conditions, Signs and Symptoms |
|
|
|
|
|
|
|
|
Hypertrophy, Left Ventricular [MESH:D017379] (1430) |
|
|
Lithiasis [MESH:D020347] (345) |
|
|
Bradycardia [MESH:D001919] (1899) |
|
|
Tachycardia [MESH:D013610] (3339) |
|
|
Aneuploidy [MESH:D000782] (1237) |
|
|
Chromosome Breakage [MESH:D019457] (139) |
|
|
Disease Progression [MESH:D018450] (2868) |
|
|
Kernicterus [MESH:D007647] (256) |
|
|
Hyperbilirubinemia, Transient Familial Neonatal [MESH:C562692] (254) |
|
|
Amenorrhea [MESH:D000568] (817) |
|
|
Neoplasm Invasiveness [MESH:D009361] (3388) |
|
|
Neoplasm Metastasis [MESH:D009362] (4441) |
|
|
Neoplasm Recurrence, Local [MESH:D009364] (1949) |
|
|
Cell Transformation, Neoplastic [MESH:D002471] (3389) |
|
|
Feminization [MESH:D005262] (655) |
|
|
Fever [MESH:D005334] (2856) |
|
|
Hypothermia [MESH:D007035] (2075) |
|
|
|
|
|
Weight Gain [MESH:D015430] (2595) |
|
|
Obesity [MESH:D009765] (4454) |
|
|
|
|
|
|
|
|
Acute Coronary Syndrome [MESH:D054058] (2286) |
|
 |
C25. Chemically-Induced Disorders |
 |
 |
|
C25. Chemically-Induced Disorders |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
|
Psychoses, Substance-Induced [MESH:D011605] (2053) |
|
|
Cocaine-Related Disorders [MESH:D019970] (3054) |
|
|
Psychoses, Substance-Induced [MESH:D011605] (2052) |
|
|
Alcoholism [MESH:D000437] (1519) |
|
 |
D02. Organic Chemicals |
 |
 |
|
D02. Organic Chemicals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hydroxyestrones [MESH:D006894] (27) |
|
 |
D04. Polycyclic Compounds |
 |
 |
|
D04. Polycyclic Compounds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hydroxyestrones [MESH:D006894] (27) |
|
|
|
|
|
|
|
|
Hydroxyestrones [MESH:D006894] (27) |
|
 |
D06. Hormones, Hormone Substitutes, and Hormone Antagonists |
 |
 |
|
D06. Hormones, Hormone Substitutes, and Hormone Antagonists |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hydroxyestrones [MESH:D006894] (27) |
|
 |
D27. Chemical Actions and Uses |
 |
 |
|
D27. Chemical Actions and Uses |
|
|
|
|
|
|
|
|
Anticarcinogenic Agents [MESH:D016588] (20) |
|
|
|
|
|
Anticarcinogenic Agents [MESH:D016588] (20) |
|
|
|
|
|
Anticarcinogenic Agents [MESH:D016588] (20) |
|
 |